FDA Drug Application (075665) for ETODOLAC by TEVA

Back to FDA Applications sponsored by TEVA

Application Number075665
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage600MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameETODOLAC
Active IngredientETODOLAC



Back to FDA Applications sponsored by TEVA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.